☆ 4.7 Article

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?

VACCINES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

Markus Hoffmann et al.

Summary: The Omicron variant of SARS-CoV-2 is spreading rapidly and shows resistance to most therapeutic antibodies. It also evades neutralization by antibodies induced by infection or vaccination more efficiently than the Delta variant. This suggests that therapeutic antibodies may not be effective against the Omicron variant, and double vaccination with BNT162b2 may not provide adequate protection against severe disease caused by this variant.

CELL (2022)

添加到收藏夹

Letter Immunology

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant

Wei Zhang et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

添加到收藏夹

Review Immunology

A global picture: therapeutic perspectives for COVID-19

Vivek P. Chavda et al.

Summary: This article provides a comprehensive overview of SARS-CoV-2 and COVID-19, including viral transmission and subsequent events in the human body. It also presents different drugs and vaccines used for the management of COVID-19. Several natural drugs are proposed for COVID-19 management, and an overview of post-COVID-19 complications in recovered patients is also provided.

IMMUNOTHERAPY (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection

Anna Wald

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

Emma K. Accorsi et al.

Summary: Assessing the performance of COVID-19 vaccines against the Omicron variant is crucial for public health guidance. This study found that receiving three doses of mRNA COVID-19 vaccine was associated with a lower likelihood of symptomatic SARS-CoV-2 infection compared to being unvaccinated or receiving two doses. These findings suggest that three doses of mRNA vaccine provide protection against both Omicron and Delta variants, though the protection against Omicron may be slightly lower.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Virology

Omicron variant genome evolution and phylogenetics

Mahmoud Kandeel et al.

Summary: The study investigates the evolutionary relationships and similarities between the Omicron variant and other SARS-CoV-2 variants, finding that the Omicron variant forms a new monophyletic clade distant from other variants.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Review Virology

Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant

Vineet Sharma et al.

Summary: The Omicron variant of COVID-19 has been detected in 149 countries and is spreading rapidly. It has become the dominant variant in South Africa and is causing a surge in cases in countries like the United Kingdom and the United States. Initial research suggests that vaccines may still be effective against the variant, but more investigation is needed to understand its real-world impact.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Editorial Material Geriatrics & Gerontology

Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?

Vivek P. Chavda et al.

MATURITAS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Lihong Liu et al.

Summary: The B.1.1.529/Omicron variant of SARS-CoV-2, initially detected in southern Africa, has rapidly spread globally and is expected to become dominant due to its enhanced transmissibility in the coming weeks. This variant poses a threat to the efficacy of current COVID-19 vaccines and antibody therapies due to its significant antibody resistance. Even individuals who have received vaccines and booster doses may have reduced neutralizing activity against B.1.1.529.

NATURE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

Henning Gruell et al.

Summary: This study demonstrates that neutralization of the SARS-CoV-2 Omicron variant is greatly reduced in individuals who received two doses of the COVID-19 vaccine or have recovered from the disease, but is significantly increased after a booster vaccine dose.

NATURE MEDICINE (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

Universal Coronavirus Vaccines - An Urgent Need

David M. Morens et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Letter Medicine, General & Internal

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

Rolando Pajon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Immunology

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

Hanjun Zhao et al.

Summary: The Omicron variant of SARS-CoV-2 has distinct virological characteristics compared to the Delta variant. It replicates more slowly and its entry pathway is mediated primarily through the endocytic pathway instead of TMPRSS2 pathway. This difference in entry pathway may have implications for the clinical manifestations or severity of the disease.

EMERGING MICROBES & INFECTIONS (2022)

添加到收藏夹

News Item Critical Care Medicine

Omicron variant and booster COVID-19 vaccines

Talha Khan Burki

LANCET RESPIRATORY MEDICINE (2022)

添加到收藏夹

Article Immunology

DNA vaccines for SARS-CoV-2: toward third-generation vaccination era

Vivek P. Chavda et al.

Summary: DNA vaccines have the potential to provide protection against SARS-CoV-2 by transforming host cells into protein factories that trigger the immune system to produce antibodies. This vaccine platform offers advantages such as strong cellular immune response, high safety margin, and simple production process, making it a robust choice for large-scale production.

EXPERT REVIEW OF VACCINES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie J. Ewer et al.

Summary: A single dose of the ChAdOx1 nCoV-19 vaccine can induce favorable immune responses that may help control or prevent SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

News Item Medicine, General & Internal

Covid-19: Early studies give hope omicron is milder than other variants

Bryan Christie

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

News Item Medicine, General & Internal

Covid-19: Omicron and the need for boosters

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

News Item Medicine, General & Internal

Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show

Owen Dyer

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

News Item Medicine, General & Internal

Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management

Vivek P. Chavda et al.

Summary: Intranasal vaccines have advantages in targeting SARS-CoV-2 infection, eliciting immune responses, and avoiding infections, while also convenient for self-administration and storage at ambient temperatures.

DRUG DISCOVERY TODAY (2021)

添加到收藏夹

Article Veterinary Sciences

Adverse Reactions to Vaccination From Anaphylaxis to Autoimmunity

Laurel J. Gershwin

VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2018)

添加到收藏夹

Article Immunology

Hepatitis B and the Need for a Booster Dose

Elke Leuridan et al.

CLINICAL INFECTIOUS DISEASES (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.